Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.
Quick Stats
Jan 30, 202652.4
AI Score
HOLD0.68
Volume Ratio
Next Earnings
15
+ve Days (30d)
14
-ve Days (30d)
IMDX Stock Summary
Last updated Jan 30, 2026
IMDX is currently trading at $6.52, positioned below its 200-day moving average of $None, suggesting bearish momentum. The stock has a 52-week range of $2.33 to $8.51.
Technical Analysis: The 50-day moving average stands at $6.2, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 48.561, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.188, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates IMDX at 52.4/100 with a HOLD recommendation.
IMDX (Insight Molecular Diagnostics Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.561 |
| CMF (20) | 0.188 |
| ROC (10) | -1.511 |
| ADX (14) | 15.124 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.077 |
| AROONOSC (14) | -64.286 |
| WILLAMS %R (14) | -65.714 |
| MFI (14) | 36.587 |
IMDX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
IMDX Price vs Max Options Open Interest
IMDX Max Change In Options Open Interest
IMDX Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMDX Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMDX Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
IMDX Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Insight Molecular Diagnostics Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
IMDX Moving Averages Analysis
Insight Molecular Diagnostics Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
IMDX (Insight Molecular Diagnostics Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 6.61 |
| 20 | 6.92 |
| 30 | 6.58 |
| 50 | 6.2 |
| 100 | 5.51 |
| 200 | None |
IMDX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 86.7 million |
| Earnings/Share ($) | -3.79 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.99 |
| EPS Estimate Next Year ($) | -0.96 |
| WallStreet Target Price ($) | 5.4167 |
| Most Recent Quarter |